Dali, China, March 1, 2021 – MicroPort® NeuroTech recently launched their TWINS Hemorrhage Treatment Solution Advanced Training and NUMEN® Spring Coil in Yunnan. The training was opened by Party Secretary Wen Sun, Secretary Sun Wen of Dali First People's Hospital, and Professor Yi Cao of the Second Affiliated Hospital of Kunming Medical University
The launch included talks from neurointerventional experts from the southwest region, who gave lectures on the Tubridge® Vascular Reconstruction Device ("Tubridge®") and the WILLIS® Intracranial Covered Stent ("WILLIS®"), both MicroPort® NeuroTech TWINS Hemorrhagic Products, as well as the NUMEN® Coil Occlusion System ("NUMEN®"). The event also included simulator demonstrations, which provided the attendees with a combination of theory and practice for an all-round comprehensive learning experience.
During his closing speech at the launch, Professor Yi Cao from the Second Affiliated Hospital of Kunming Medical University stated, “With the continuous development and advancement of domestic neurointerventional materials, there will be more opportunities for the development of domestic neurointervention technologies.
MicroPort® NeuroTech is committed to continuing development and innovation in the field of neurointervention to provide more efficient and universal solutions for patients and doctors, and is committed to become a "total solution provider for cerebral apoplexy."
About NUMEN® Coil Occlusion System:
NUMEN® coils provide physicians with a reliable new option in the interventional treatment of intracranial aneurysms. As the primary treatment for intracranial aneurysms, the degree of dense filling of the coil is closely related to aneurysm recurrence rate. NUMEN® has been cleverly designed and repeatedly tested to achieve both stable positioning and flexible embolization, making it clinically effective and safe for basket formation, finishing and filling in embolized aneurysms.
About MicroPort® NeuroTech TWINS Hemorrhagic Products:
Tubridge® adopts the concept of vascular reconstruction with higher metal coverage, more flexible stents, more size options, and good wall adherence, which receives positive feedback from the experts. Long-term follow-up results show that aneurysms treated with Tubridge® have mostly healed with satisfactory results. Clinical cases have also shown that the WILLIS® covered stents have brought hope to interventional treatment of difficult diseases such as carotid cavernous fistula (CCF) and blood blister-like aneurysm.